Awarded FIRST PLACE
Concenter BioPgharma' Type 2 Diabetes Drug - "Zygosid-50" has been awarded FIRST PLACE.
At the 17th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), December 7th, 2019 in Los Angeles. Prof. Mottie Chevion, CSO, received the award from Zachary Bloomgarden, MD.
It is a great honor to receive this recognition for our achievements from the global leading researchers, physicians-clinicians and other healthcare professionals in the field!
The Congress is the premier global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease (CVD), and energy balance, linking basic research to clinical practice in pursuit of the theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.